Yusuke Doi

978 citations

37 papers · 797 indexed · h-index 16

Impact in

Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Molecular Biology
- RNA Interference and Gene Delivery
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- Advanced biosensing and bioanalysis techniques

Papers in ⓘ

Molecular Biology 24
- Molecular Biology Techniques and Applications 6
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 3
Biomaterials 12
- Nanoparticle-Based Drug Delivery 12

Co-authors: Tatsuhiro Ishida (17 shared papers)Hiroshi Kiwada (10 shared papers)Amr S. Abu Lila (11 shared papers)Takuya Suzuki (3 shared papers)Yuji Yamamoto (7 shared papers)Satoru Miyaishi (7 shared papers)Kazuya Nakamura (3 shared papers)Hideo Ishizu (6 shared papers)
Journals: Legal Medicine (3 papers)Journal of Controlled Release (3 papers)International Journal of Pharmaceutics (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Forensic Science International (2 papers)
Partner nations: Japan Egypt Saudi Arabia

In The Last Decade

Yusuke Doi

37 papers receiving 784 citations

Peers

Countries citing papers authored by Yusuke Doi

Since Specialization

Citations

This map shows the geographic impact of Yusuke Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Doi more than expected).

Fields of papers citing papers by Yusuke Doi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Doi. The network helps show where Yusuke Doi may publish in the future.

Co-authors

The 25 scholars most cited alongside Yusuke Doi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yusuke Doi Line = papers co-authored together Yusuke Doi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylases Genes & Development ·Yuji Funakoshi, Yusuke Doi, Nao Hosoda, Naoyuki Uchida, Masanori Osawa, Ichio Shimada, Masafumi Tsujimoto, Tsutomu Suzuki, Toshiaki Katada, S. Hoshino	2007	146
2	Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model Journal of Controlled Release ·Amr S. Abu Lila, Shinji Kizuki, Yusuke Doi, Takuya Suzuki, Tatsuhiro Ishida, Hiroshi Kiwada	2009	95
3	A new 39-plex analysis method for SNPs including 15 blood group loci Forensic Science International ·Sachiyo Inagaki, Yuji Yamamoto, Yusuke Doi, T. Takata, Takaki Ishikawa, Kiyomi Imabayashi, Kei Yoshitome, Satoru Miyaishi, Hideo Ishizu	2004	54
4	Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model Journal of Controlled Release ·Amr S. Abu Lila, Takuya Suzuki, Yusuke Doi, Tatsuhiro Ishida, Hiroshi Kiwada	2008	52
5	A Double-modulation Strategy in Cancer Treatment With a Chemotherapeutic Agent and siRNA Molecular Therapy ·Kazuya Nakamura, Amr S. Abu Lila, Mariko Matsunaga, Yusuke Doi, Tatsuhiro Ishida, Hiroshi Kiwada	2011	52
6	Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor Journal of Controlled Release ·Amr S. Abu Lila, Yusuke Doi, Kazuya Nakamura, Tatsuhiro Ishida, Hiroshi Kiwada	2009	46
7	A new method for ABO genotyping using a multiplex single-base primer extension reaction and its application to forensic casework samples Legal Medicine ·Yusuke Doi, Yuji Yamamoto, Sachiyo Inagaki, Yoshiaki Shigeta, Satoru Miyaishi, Hideo Ishizu	2004	37
8	Combination therapy of metronomic S‐1 dosing with oxaliplatin‐containing polyethylene glycol‐coated liposome improves antitumor activity in a murine colorectal tumor model Cancer Science ·Yusuke Doi, Tomoko Okada, Haruna Matsumoto, Masako Ichihara, Tatsuhiro Ishida, Hiroshi Kiwada	2010	33
9	Long-term storage of PEGylated liposomal oxaliplatin with improved stability and long circulation times in vivo International Journal of Pharmaceutics ·Yusuke Doi, Taro Shimizu, Yu Ishima, Tatsuhiro Ishida	2019	33
10	Use of EF-Tu mutants for determining and improving aminoacylation efficiency and for purifying aminoacyl tRNAs with non-natural amino acids The Journal of Biochemistry ·Takashi Ohtsuki, Hidetaka Yamamoto, Yusuke Doi, Masahiko Sisido	2010	21
11	Sequential treatment of oxaliplatin-containing PEGylated liposome together with S-1 improves intratumor distribution of subsequent doses of oxaliplatin-containing PEGylated liposome European Journal of Pharmaceutics and Biopharmaceutics ·Hiroyuki Nakamura, Yusuke Doi, Amr S. Abu Lila, Ai Nagao, Tatsuhiro Ishida, Hiroshi Kiwada	2013	21
12	Identification and evaluation of potential forensic marker proteins in vaginal fluid by liquid chromatography/mass spectrometry Analytical and Bioanalytical Chemistry ·Akihisa Igoh, Yusuke Doi, Koichi Sakurada	2015	21
13	Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model Cancer Science ·Taro Shimizu, Amr S. Abu Lila, Miho Nishio, Yusuke Doi, Hidenori Ando, Masami Ukawa, Yu Ishima, Tatsuhiro Ishida	2017	21
14	Synthesis and characterization of oligonucleotides containing 2'-fluorinated thymidine glycol as inhibitors of the endonuclease III reaction Nucleic Acids Research ·Yusuke Doi	2006	19
15	Immunoliposomal drug-delivery system targeting lectin-like oxidized low-density lipoprotein receptor–1 for carotid plaque lesions in rats Journal of neurosurgery ·Atsushi Saito, Hiroaki Shimizu, Yusuke Doi, Tatsuhiro Ishida, Miki Fujimura, Takashi Inoue, Hiroshi Kiwada, Teiji Tominaga	2011	17
16	Typing of Y chromosome single nucleotide polymorphisms in a Japanese population by a multiplexed single nucleotide primer extension reaction Legal Medicine ·Sachiyo Inagaki, Yuji Yamamoto, Yusuke Doi, T. Takata, Takaki Ishikawa, Kei Yoshitome, Satoru Miyaishi, Hideo Ishizu	2002	15
17	Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin European Journal of Pharmaceutics and Biopharmaceutics ·Amr S. Abu Lila, Haruna Matsumoto, Yusuke Doi, Hiroyuki Nakamura, Tatsuhiro Ishida, Hiroshi Kiwada	2012	14
18	Quantitative analysis of DNA degradation in the dead body. PubMed ·Miki Itani, Yuji Yamamoto, Yusuke Doi, Satoru Miyaishi	2011	13
19	Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing International Journal of Nanomedicine ·Yusuke Doi, Amr S. Abu Lila, Haruna Matsumoto, Tomoko Okada, Taro Shimizu, Tatsuhiro Ishida	2016	12
20	Detection of proline-rich proteins for the identification of saliva by enzyme-linked immunosorbent assay Legal Medicine ·Akihisa Igoh, Sho Tomotake, Yusuke Doi	2015	12

About Yusuke Doi

Yusuke Doi is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Genetics and Oncology, having authored 37 papers that have together received 797 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (9 papers), Forensic and Genetic Research (8 papers), Molecular Biology Techniques and Applications (6 papers), RNA Interference and Gene Delivery (5 papers), Cancer Treatment and Pharmacology (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Blood groups and transfusion (3 papers). The work is most often cited by research in Biomaterials (282 citations), Molecular Biology (535 citations), Pharmaceutical Science (36 citations), Biomedical Engineering (195 citations) and Oncology (121 citations). Yusuke Doi has collaborated with scholars based in Japan, Egypt and Saudi Arabia. Frequent co-authors include Tatsuhiro Ishida, Hiroshi Kiwada, Amr S. Abu Lila, Takuya Suzuki, Yuji Yamamoto, Satoru Miyaishi, Kazuya Nakamura, Hideo Ishizu, Masanori Osawa and Toshiaki Katada. Their work appears in journals such as Legal Medicine, Journal of Controlled Release, International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics and Forensic Science International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact